Revelation Biosciences Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Recent Corporate Progress
Provided By Globe Newswire
Last update: Aug 15, 2022
SAN DIEGO, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, today reported its second quarter 2022 financial results and highlighted recent corporate progress.
NASDAQ:REVB (4/25/2025, 8:00:01 PM)
2.92
-0.01 (-0.34%)
NASDAQ:REVBW (4/25/2025, 8:00:01 PM)
0.0108
0 (-28%)
Find more stocks in the Stock Screener
REVB Latest News and Analysis
19 days ago - ChartmillWondering what's happening in today's after-hours session?Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
